We are live on ! Find out more
Envestnet Asset Management

Envestnet Asset Management Portfolio holdings

AUM $424B
1-Year Est. Return 22.96%
 

Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.

This Fund
S&P 500
This Quarter Est. Return
-5.47%
1 Year Est. Return
+22.96%
3 Year Est. Return
+65.02%
5 Year Est. Return
+65.25%
10 Year Est. Return
+249.9%
AUM
$175B
AUM Growth
-$3.74B
Cap. Flow
+$7.33B
Cap. Flow %
4.18%
Top 10 Hldgs %
25.6%
Holding
4,115
New
205
Increased
2,159
Reduced
1,481
Closed
219

Sector Composition

Rank Sector Weight
1 Technology 5.75%
2 Healthcare 4.62%
3 Financials 3.92%
4 Consumer Discretionary 2.76%
5 Industrials 2.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKTS
3826
DELISTED
Akoustis Technologies Inc
AKTS
$34K ﹤0.01%
11,297
-2,512
-18% -$10.2K
EGIO
3827
DELISTED
Edgio, Inc. Common Stock
EGIO
$34K ﹤0.01%
+303
New +$35.9K
MESO
3828
Mesoblast
MESO
$2.16B
$33K ﹤0.01%
+6,527
New +$39.5K
MREO
3829
Mereo BioPharma
MREO
$43.5M
$32K ﹤0.01%
+37,367
New +$45.7K
WINT
3830
DELISTED
Windtree Therapeutics
WINT
$32K ﹤0.01%
+2
New +$35.7K
WPRT
3831
Westport Fuel Systems
WPRT
$35.7M
$31K ﹤0.01%
3,591
AMRN
3832
Amarin Corp
AMRN
$298M
$30K ﹤0.01%
1,390
+199
+17% +$5.34K
AMTD
3833
AMTD IDEA Group
AMTD
$71M
$30K ﹤0.01%
4,157
+499
+14% +$5.74K
REFR icon
3834
Research Frontiers
REFR
$17.1M
$30K ﹤0.01%
14,000
XYLO
3835
DELISTED
Xylo Technologies
XYLO
$30K ﹤0.01%
1,342
+17
+1% +$414
SOLO
3836
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$30K ﹤0.01%
24,270
GOEV
3837
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$30K ﹤0.01%
35
+6
+21% +$8.75K
CMMB
3838
Chemomab Therapeutics
CMMB
$13.8M
$29K ﹤0.01%
2,929
-119
-4% -$1.53K
BLRX
3839
BioLineRX
BLRX
$11.8M
$28K ﹤0.01%
746
-538
-42% -$30.7K
UGP icon
3840
Ultrapar
UGP
$6.42B
$28K ﹤0.01%
12,872
+178
+1% +$446
YRD
3841
Yiren Digital
YRD
$109M
$27K ﹤0.01%
25,407
+2,367
+10% +$2.97K
AMBR
3842
Amber International Holding Ltd
AMBR
$125M
$26K ﹤0.01%
7,522
-309
-4% -$1.57K
MIR.WS
3843
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$26K ﹤0.01%
17,634
+70
+0.4% +$95
PGEN icon
3844
Precigen
PGEN
$2.51B
$25K ﹤0.01%
11,633
-1,556
-12% -$3.28K
RNLX
3845
DELISTED
Renalytix plc American Depositary Shares
RNLX
$22K ﹤0.01%
17,288
+325
+2% +$708
ATIP
3846
DELISTED
ATI Physical Therapy, Inc.
ATIP
$21K ﹤0.01%
425
-10
-2% -$569
SYBX
3847
DELISTED
Synlogic
SYBX
$20K ﹤0.01%
1,404
+419
+43% +$6.42K
ZEPP
3848
Zepp Health
ZEPP
$76.1M
$19K ﹤0.01%
3,410
-2,363
-41% -$17.1K
INO icon
3849
Inovio Pharmaceuticals
INO
$76.1M
$18K ﹤0.01%
+851
New +$21.8K
AUGX
3850
DELISTED
Augmedix, Inc. Common Stock
AUGX
$18K ﹤0.01%
12,578
+2,247
+22% +$3.85K

Similar funds

Envestnet Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Envestnet Asset Management held 4,115 positions worth $175B, down 2.1% from $179B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Envestnet Asset Management deployed $7.33B of net new capital in Q3 2022, opening 205 new positions and adding to 2,159 existing holdings. Its largest new stake was GSK: 622,292 shares worth $18.3M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 5.9% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $1.23B trimmed.

  • Envestnet Asset Management's largest Q3 2022 buy was GSK: 622,292 shares worth $18.3M.
  • Envestnet Asset Management added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $1.9B increase.
  • Envestnet Asset Management's biggest Q3 2022 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $1.23B.
  • Envestnet Asset Management fully exited Atlassian in Q3 2022, selling an estimated $67.3M.
  • Envestnet Asset Management's ten largest holdings make up 26% of its $175B portfolio in Q3 2022.
  • Envestnet Asset Management opened 205 new positions and closed 219 in Q3 2022.
  • Envestnet Asset Management's portfolio value fell 2.1% quarter-over-quarter to $175B.

Based on Envestnet Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.